Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856462
SERIAL NO

14740194

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY;SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL;KOREAN ADVANCED INSITITUTE OF SCIENCE AND TECHNOLOGY (KAIST)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hong, Hye Kyoung Seongnam, KR 1 9
Kim, Ho Min Daejeon, KR 11 25
Lim, Eun-Jin Daejeon, KR 1 9
Park, Kyu Hyung Seongnam, KR 3 10
Woo, Se Joon Seongnam, KR 5 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00